Lifeforce Capital

Lifeforce Capital is an early-stage venture capital firm based in San Francisco, California, dedicated to investing in transformative digital health companies. The firm primarily focuses on startups that are pioneering new care delivery models or enhancing the efficiency of therapeutic development. Their investment thesis centers on leveraging technology to address critical challenges within the healthcare ecosystem, aiming to improve patient outcomes, reduce costs, and expand access to care.

Lifeforce Capital actively seeks out innovative solutions across various segments of digital health, including virtual care platforms, AI-driven diagnostics and drug discovery, precision medicine, and patient engagement tools. They partner with visionary founders who are building scalable businesses designed to reshape how healthcare services are consumed and delivered, from prevention and diagnosis to treatment and ongoing management.

As an early-stage investor, Lifeforce Capital typically leads or co-leads Seed and Series A funding rounds. Their initial check size for investments generally ranges from $1 million to $5 million, providing substantial early capital to promising ventures. The firm announced its inaugural fund, Lifeforce Capital I, which closed at $50 million in 2021, demonstrating their commitment and capacity to support a focused portfolio of digital health innovators.

Beyond capital, Lifeforce Capital positions itself as a strategic partner, offering operational guidance, industry expertise, and access to a robust network of healthcare professionals and entrepreneurs. This hands-on approach is designed to help portfolio companies navigate the complex healthcare landscape, accelerate product development, achieve market validation, and scale their operations effectively, contributing to the broader evolution of healthcare.